Company profile: ProAxsis
1.1 - Company Overview
Company description
- Provider of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection, and measurement of active protease biomarkers of disease, incorporating patented ProteaseTags smart molecules that selectively trap active proteases and deliver a visual readout in complex biological samples.
Products and services
- Laboratory-based immunoassays: ProAxsis develops laboratory-based immunoassays that capture, detect, and measure active protease biomarkers within complex biological samples for disease monitoring and research
- ProteaseTag® Technology: Patented ProteaseTags® are unique smart molecules that rapidly and selectively bind and trap active proteases in complex biological samples, generating a clear visual readout of protease activity
- Rapid point-of-care tests: ProAxsis engineers easy-to-use point-of-care tests incorporating ProteaseTags® to quickly capture, detect, and measure active proteases in complex samples, delivering immediate visual readouts of protease activity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProAxsis
Covalon
HQ: Canada
Website
- Description: Provider of healthcare technologies for wound care and IV site protection, including CovaWound Foam non-adherent dressings, CovaWound Hydrocolloid Dressings for light exuding wounds, ColActive PLUS Ag collagen dressings with silver for antimicrobial protection, IV Clear transparent dressings to secure IV sites, and VALGuard to safeguard IV connections and reduce infection risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Covalon company profile →
Cellzome
HQ: Germany
Website
- Description: Provider of kinase-targeted drugs and oral kinase inhibitor therapeutics for inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma; engaged in discovery, development, and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellzome company profile →
Jena Bioscience
HQ: Germany
Website
- Description: Provider of biotechnology products, including isothermal amplification and LAMP products for rapid DNA/RNA analysis, ready-to-use lyophilized PCR mixes in 96-well plates, contamination detection controls for food, cell cultures and nucleic acids, RNA/DNA preparation and cleanup kits with magnetic bead options, and click reagents for lipid and posttranslational modification analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jena Bioscience company profile →
Tentarix
HQ: United States
Website
- Description: Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentarix company profile →
Advanced Analytical Technologies
HQ: United States
Website
- Description: Provider of high-throughput, fully-automated nucleic acid and genetic analysis systems for commercial and research applications, designed to improve processes in the molecular diagnostics, pharmaceutical, life science, agricultural, and biofuels industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Analytical Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProAxsis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProAxsis
2.2 - Growth funds investing in similar companies to ProAxsis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProAxsis
4.2 - Public trading comparable groups for ProAxsis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →